Pulmonology
Commentary
Is air filtration the best public health intervention against respiratory viruses?
The idea is that those ions stick to the virus particles ... and that tends to cause them to clump together and settle on surfaces more rapidly,...
News from the FDA/CDC
High school students using less tobacco, vape products, CDC report shows
“Sustained efforts to prevent initiation of tobacco product use among young persons and strategies to help young tobacco users quit are critical...
Commentary
Upper respiratory infections: Viral testing in primary care
Test results will help guide not only treatment decisions but also infection control measures.
From the Journals
Minimally invasive surfactant shows some benefit in infants’ first 2 years
MIST, compared with sham treatment, did not reduce death or neurodevelopmental disability, but infants who received MIST had lower rates of poor...
News from the FDA/CDC
FDA panel deems phenylephrine ineffective
The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.
From the Journals
Young vapers and smokers beware: Eye problems abound
Use of both cigarettes and vapes is apparently much worse for eye health than either product use alone, a new study found.
From the Journals
Healthy babies can still get very sick from RSV
The study challenges the assumption that only infirm children are at risk for the worst outcomes from RSV.
Latest News
U.S. has new dominant COVID variant called EG.5
Called “Eris” among avid COVID trackers, the strain EG.5 now accounts for 17% of all U.S. COVID infections.
From the Journals
Phenotypes drive antibiotic response in youth with bronchiectasis
Ethnicity and auscultatory findings were factors predicting response; data may improve antibiotic stewardship.
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.
ID Consult
Profile of respiratory bacteria in children younger than 6 months
Researchers provide heretofore unreported contemporary data in a highly PCV13-immunized, community-based child population in the United States.